Literature DB >> 11012137

Yield and costs of screening growth-retarded infants for torch infections.

N A Khan1, S N Kazzi.   

Abstract

Many infants with intrauterine growth retardation (IUGR) are screened for TORCH infections. The yield and costs of such a practice may not be justifiable. Medical charts of infants with IUGR who had a workup for toxoplasmosis, other (infections), rubella, cytomegalovirus (infection), and herpes (simplex) (titer) (TORCH) infections were reviewed for the presence of clinical findings, laboratory and head ultrasound abnormalities associated with intrauterine infections. Maternal charts and reports of placental pathology were reviewed for identifying maternal illnesses and placental causes associated with IUGR. Seventy-five out of 182 infants (41%) with IUGR had a workup for TORCH infection. Maternal conditions associated with IUGR included: pregnancy-induced hypertension (19%), tobacco use (43%), alcohol abuse (21%), illicit drug use (24%), chronic hypertension, diabetic vasculopathy or collagen vascular disease (12%), and multiple gestation (3%). Placental pathology was available in 53/75 cases. Thirty-six of fifty-three (67%) placentae had abnormalities associated with IUGR: placental infarcts (22 of 36), vasculitis/villitis (15 of 36), placenta previa (1 of 36), abruptio placenta (2 of 36), and velamentous insertion of umbilical cord (1 of 36). Clinical findings among infants included hepatosplenomegaly, cataract or rash (1 of 75), thrombocytopenia and/or neutropenia and/or direct hyperbilirubinemia (11 of 75). Seven out of 75 infants had dysmorphic features. None of the infants (0 of 75) had positive IgM titers for toxoplasma, rubella, cytomegalovirus (CMV), or herpes simplex virus (HSV). No infants (0 of 43) had elevated total IgM titers; one infant (1 of 57) had a positive urine culture for CMV. One infant had evidence of calcifications on head ultrasound and a second infant had hydrocephalus (2 of 43). The costs associated with workup for TORCH infections among 75 infants included: TORCH titers determination: $17,816, total IgM titers: $1318, urine culture for CMV: $5734, and head ultrasound: $28,165. The yield of workup for TORCH infection among infants with IUGR is poor and does not justify the incurred costs.

Entities:  

Mesh:

Year:  2000        PMID: 11012137     DOI: 10.1055/s-2000-9288

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  6 in total

1.  Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus using a novel multiplex flow immunoassay.

Authors:  M J Binnicker; D J Jespersen; J A Harring
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

2.  Routine Screening for Rubella and CMV Antibodies During Pregnancy: Is it Justifiable?

Authors:  Anita Chakravarti; Abha Sharma; Monika Matlani
Journal:  J Obstet Gynaecol India       Date:  2013-07-12

3.  Screening investigations in small-for-gestational-age near-term and term infants.

Authors:  Mohan B Krishnamurthy; Abigail Popiel; Atul Malhotra
Journal:  Eur J Pediatr       Date:  2017-10-10       Impact factor: 3.183

4.  Construction and implications of structural equation modeling network for pediatric cataract: a data mining research of rare diseases.

Authors:  Erping Long; Shuangjuan Xu; Zhenzhen Liu; Xiaohang Wu; Xiayin Zhang; Jinghui Wang; Wangting Li; Runzhong Liu; Zicong Chen; Kexin Chen; Tongyong Yu; Dongxuan Wu; Xutu Zhao; Jingjing Chen; Zhuoling Lin; Qianzhong Cao; Duoru Lin; Xiaoyan Li; Jingheng Cai; Haotian Lin
Journal:  BMC Ophthalmol       Date:  2017-05-19       Impact factor: 2.209

5.  Microsphere-based antibody assays for human parvovirus B19V, CMV and T. gondii.

Authors:  Yilin Wang; Lea Hedman; Maria F Perdomo; Amal Elfaitouri; Agnes Bölin-Wiener; Arun Kumar; Maija Lappalainen; Maria Söderlund-Venermo; Jonas Blomberg; Klaus Hedman
Journal:  BMC Infect Dis       Date:  2016-01-08       Impact factor: 3.090

6.  TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus) screening of small for gestational age and intrauterine growth restricted neonates: efficacy study in a single institute in Korea.

Authors:  Mi Hae Chung; Chan Ok Shin; Juyoung Lee
Journal:  Korean J Pediatr       Date:  2018-04-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.